[SBU should investigate what is an evidence-based and cost-effective use of statins]

Lakartidningen. 2009 Aug;106(32-33):1992-4.

[Article in Swedish]

Authors

Paul Hjemdahl¹, Anette Allhammar, Claire Heaton, Johan Hulting, Thomas Kahan, Rickard Malmström, Arne Martinsson, Franz Rücker, Karin Schenck-Gustafsson, Jonas Schwieler, Mattias Törnerud, Björn Wettermark

Affiliation

¹ Karolinska universitetssjukhuset, Solna. [email protected]

PMID: 19764381

No abstract available

MeSH terms

Anticholesteremic Agents / administration & dosage
Anticholesteremic Agents / economics
Anticholesteremic Agents / therapeutic use*
Cardiovascular Diseases / prevention & control
Cost-Benefit Analysis
Drug Utilization / economics
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Simvastatin / administration & dosage
Simvastatin / economics
Simvastatin / therapeutic use*
Sweden

Substances

Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin